Daaso Pharmaceuticals Private Limited

Daaso Pharmaceuticals Private Limited - pharma in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
CIN U74999MH2018PTC305693 Incorporated 27 February 2018 ROC Nagpur HQ Nagpur, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹1.31 Cr
▲ 23% YoY
Net loss · FY 2025
₹49.26 Lakh
Net margin -37.6%
EBITDA · FY 2025
-₹49.23 Lakh
EBITDA margin -37.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Daaso Pharmaceuticals Private Limited

Data last updated:

Daaso Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 February 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U74999MH2018PTC305693. Its GSTIN is 27AAGCD5624C1ZX (Maharashtra).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Pallavi Amarjeet Wagh and Sushil Tarachand Bagde.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P. No.138 H. No. 180 Chandanshesh Nagar Anjani H. So. Hud Layout, Nagpur, Maharashtra, India – 440034.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.31 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net loss of ₹49.26 Lakh (net margin -37.6%) and EBITDA of -₹49.23 Lakh (EBITDA margin -37.5%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 20% over five years.

The company is associated with 1 brand: DAASO Pharma.

For more details, the company can be reached via its website daasopharma.com.

Company details

CIN U74999MH2018PTC305693
Registration Number 305693
Incorporation Date 27 February 2018
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025

Contact details

Daaso Pharmaceuticals Private Limited's registered office is in Nagpur, Maharashtra. Its website is daasopharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    P. No.138 H. No. 180 Chandanshesh Nagar Anjani H. So. Hud Layout, Nagpur, Maharashtra, India – 440034
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Daaso Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Daaso Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Daaso Pharmaceuticals operates one associated brand: DAASO Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical manufacturing, exporting, and supplying of medicines in India.daasopharma.com

Business activity

The main business activity of Daaso Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Daaso Pharmaceuticals Private Limited, buy the company report.

Financials of Daaso Pharmaceuticals Private Limited

FY 2025 filings available

Daaso Pharmaceuticals Private Limited reported revenue of ₹1.31 Cr (up 23% YoY) for FY 2025.

Revenue · FY 2025
₹1.31 Cr ▲ 23%
Net loss · FY 2025
₹49.26 Lakh margin -37.6%
EBITDA · FY 2025
-₹49.23 Lakh margin -37.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 20%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▼ 243%
3 years · compounded
▼ 356%
5 years · compounded
▼ 69%

Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 23% growth in the latest year. EBITDA fell 243% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹49.23 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹49.26 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-37.5%
Net Profit Margin-37.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Daaso Pharmaceuticals Private Limited, buy the company report.

Board of directors of Daaso Pharmaceuticals Private Limited

Daaso Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Pallavi Amarjeet WaghDirector23 Nov 20196 Years 11 MonthsCurrent
Sushil Tarachand BagdeDirector27 Feb 20188 Years 8 MonthsCurrent
Deepak Hiralal GajghateDirector06 Jun 20224 Years 4 MonthsCurrent

Auditor

Daaso Pharmaceuticals Private Limited is audited by ASHISH KISHOR SHIVHARE & CO for the financial year 2019.

Auditor firmFinancial yearFirm registration number
ASHISH KISHOR SHIVHARE & COFY 2019128341W

Shareholding

The shareholding of Daaso Pharmaceuticals Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Daaso Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Daaso Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Daaso Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAGCD5624C1ZXMaharashtraActive04 May 2018

To see the full GST registrations and return filing status of Daaso Pharmaceuticals Private Limited, buy the company report.

Recent activity

Daaso Pharmaceuticals Private Limited has 5 board changes on record since 2018: 3 appointments and 2 cessations. The latest: Dhairyasheel Sharadrao Wagh ceased to be Director on 05 Mar 2024.

AGM
Daaso Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Daaso Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Nagpur.
Ceased
Dhairyasheel Sharadrao Wagh ceased to be Director.
Ceased
Dipali Deepak Gajghate ceased to be Director.
Appointed
Deepak Hiralal Gajghate was appointed as Director.
Appointed
Pallavi Amarjeet Wagh was appointed as Director.
Appointed
Sushil Tarachand Bagde was appointed as Director.
Incorporation
27 Feb 2018
Daaso Pharmaceuticals Private Limited was registered on 27 Feb 2018 with Roc Nagpur & aged 8 years 8 months as per MCA records.

Frequently asked questions

Daaso Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 February 2018 (8+ years old) and is registered under CIN U74999MH2018PTC305693.

Daaso Pharmaceuticals has 3 current directors:

The latest financial statements of Daaso Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Daaso Pharmaceuticals is 27AAGCD5624C1ZX, registered in Maharashtra.

The CIN (Corporate Identification Number) of Daaso Pharmaceuticals is U74999MH2018PTC305693. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Daaso Pharmaceuticals was incorporated on 27 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Nagpur.

Dhairyasheel Sharadrao Wagh ceased to be Director on 05 Mar 2024. Dipali Deepak Gajghate ceased to be Director on 08 Jun 2022. Deepak Hiralal Gajghate was appointed as Director on 06 Jun 2022. Daaso Pharmaceuticals has 5 board changes on record in total.

Daaso Pharmaceuticals can be reached through the website daasopharma.com. Its registered office is in Nagpur, Maharashtra, India.

The registered office of Daaso Pharmaceuticals is at P. No.138 H. No. 180 Chandanshesh Nagar Anjani H. So. Hud Layout, Nagpur, Maharashtra, India – 440034.

Daaso Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.